Integrative Neuroscience of Cognition and Aging (@inca_lab) header
Integrative Neuroscience of Cognition and Aging (@inca_lab) profile picture

PI: Taylor W. Schmitz (@taylorwschmitz). Unofficial cholinergic system fan club. @WesternU

London, Ontario
Joined June 2019
Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)Photo by Integrative Neuroscience of Cognition and Aging (@inca_lab)
3/4 🧬Evidence from both mouse and human data suggests that the BF structure-function gradient is shaped by a tradeoff between the complexity of cholinergic neuron branching and the distance they travel to their cortical targets.
1
181
4/4 Our findings reveal that biophysical constraints lead certain BF cholinergic neurons to exhibit greater modularity, while others show greater diffusivity in their functional integration with cortical targets
148
Integrative Neuroscience of Cognition and Aging retweeted
A paper in @NatureMedicine reports that a phase 2a trial of drug candidate LM11A-31 in mild to moderate Alzheimer disease suggests that p75 neurotrophin receptor modulation is safe and attenuates measures of degeneration. go.nature.com/4bKzJhx
7
1
37
18,773
1/4 New paper out from @inca_lab with @hayleyrcshanks taking the pilot seat! nature.com/articles/s41591-0…. This is the culmination of a years-long collaboration with Drs. Frank Longo @StanfordMed @FrankLo52652180 and Stephen Massa @UCSFMedicine.
1
2
1
8
1,841
3/4 The trial met its primary endpoint of safety and tolerability. Our team analyzed the trial’s multiple secondary and exploratory endpoints, which included cerebrospinal fluid, structural magnetic resonance imaging (MRI) and FDG positron emission tomography (PET).
1
120
4/4 Despite the relatively short 26-week duration of the trial, we demonstrate that LM11A-31 slowed disease progression on markers of synaptic integrity and inflammation in the cerebrospinal fluid, as well as cerebral gray matter (MRI) and glucose metabolism (PET).
116
Integrative Neuroscience of Cognition and Aging retweeted
#SchulichMedDent's PhD candidate Hayley Shanks may play for Western's women's football team, but off the field, she's tackling Alzheimer’s disease through her research. Read more in this story by Makaila Atsonglo. ⤵️ brnw.ch/21wGzrh
7
1
21
3,367
Each of these reviews has a companion primary research article forthcoming - Stay tuned!
2
152
(part 2) @hayleyrcshanks discusses the p75 neurotrophin receptor as a drug target for promoting neuronal resilience to Alzheimer's disease dx.doi.org/10.14283/jpad.202…. With collaborators Frank Longo and Stephen Massa @StanfordMed and an assist from @k8onuska.
2
137
Congratulations Dr. Sudesna Chakraborty @SudesnaC!!! Newly minted PhD! Read about some of Sudesna's work here: biorxiv.org/content/10.1101/…
1
1
1
202
Double congratulations to @BahaaldinHelal for successful defense of your Master of Engineering Science and admission to University of Toronto med school!
1
7
1,065
@inca_lab is representing at #ADPD2023 with talks from @k8onuska, @hayleyrcshanks, @taylorwschmitz this Friday and a poster from @BahaaldinHelal Screenshots attached for reference.
3
155